EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ebola vaccine in a nasal spray? early trial halted
⭐️ VACCINE ⭐️ TerminatedThis early-stage trial tested a nasal spray vaccine against Ebola in 15 healthy adults. The vaccine uses a weakened common cold virus to deliver a piece of the Ebola virus. The study aimed to check safety and immune response, but it was terminated early, so results are limited.
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:03 UTC
-
UK volunteers test new ebola vaccine combo in Early-Stage trial
⭐️ VACCINE ⭐️ TerminatedThis early-stage trial tested the safety and immune response of two experimental Ebola vaccines in 38 healthy UK adults. Some volunteers received one vaccine, while others got a prime-boost combination. The vaccines use harmless viruses to train the immune system against Ebola wi…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:05 UTC